{
    "clinical_study": {
        "@rank": "65285", 
        "arm_group": [
            {
                "arm_group_label": "EA group", 
                "arm_group_type": "Experimental", 
                "description": "Electroacupuncture group"
            }, 
            {
                "arm_group_label": "MOX group", 
                "arm_group_type": "Experimental", 
                "description": "Herbs-partitioned moxibustion group"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether acupuncture or moxibustion therapies are\n      effective in the treatment of Crohn's disease. Meanwhile, the investigators aim to evaluate\n      the efficacy by functional magnetic resonance imaging."
        }, 
        "brief_title": "Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With fMRI", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Crohn's Disease", 
            "CAM"
        ], 
        "condition_browse": {
            "mesh_term": "Crohn Disease"
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to determine whether acupuncture or moxibustion therapies are\n      effective in the treatment of Crohn's disease. meanwhile, the investigators aim to evaluate\n      the efficacy by functional magnetic resonance imaging.\n\n      Through treating quiescent Crohn's disease by electroacupuncture or moxibustion therapies\n      for 12 weeks, Compare the different brain activation by the different therapies and observe\n      the correlation between brain activation and efficacy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age 18-50 years;\n\n          -  right-handed;\n\n          -  clinical remission (Crohn's Disease Activity Index [CDAI]\u2264150) for at least 6 months\n             prior to the study;\n\n          -  C-reactive protein(CRP)<10 mg/l;\n\n          -  erythrocyte sedimentation rate (ESR) <20 mm/h\n\n          -  signing awritten informed consent form.\n\n        Exclusion Criteria:\n\n          -  use of corticosteroids and psychotropic medications in the previous 30 days;\n\n          -  current or prior history of neurological or psychiatric disease based\n\n          -  on physicians' examination and questionnaires;\n\n          -  current or prior history of neurosurgery, head injury, cerebrovascular\n\n          -  insult, or brain trauma involving loss of consciousness;\n\n          -  learning disability;\n\n          -  claustrophobia;\n\n          -  presence of metallic implants in the body;\n\n          -  being pregnant or during lactation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01696838", 
            "org_study_id": "SHACU-201201"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "EA group", 
                    "MOX group"
                ], 
                "description": "Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.", 
                "intervention_name": "electroacupuncture", 
                "intervention_type": "Other", 
                "other_name": "acupuncture"
            }, 
            {
                "arm_group_label": [
                    "EA group", 
                    "MOX group"
                ], 
                "description": "patients receive herbs-partitioned moxibustion for 2 cones\uff0c3 times a week for 12 weeks.", 
                "intervention_name": "moxibustion", 
                "intervention_type": "Other", 
                "other_name": "herbs-partitioned moxibustion"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Crohn's disease", 
            "acupuncture", 
            "moxibustion", 
            "fMRI", 
            "Gut"
        ], 
        "lastchanged_date": "October 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200030"
                }, 
                "name": "Shanghai Institute of Acupuncture-Moxibustion and Merdian"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With Functional Magnetic Resonance Imaging(fMRI)", 
        "overall_official": {
            "affiliation": "Shanghai Institute of Acupuncture, Moxibustion and Meridian", 
            "last_name": "Wu Huangan, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "China: Ethics Committee"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Crohn's Disease Activity Index", 
            "measure": "CDAI", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01696838"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Brain activiation tested by BOLD fMRI", 
                "measure": "fMRI", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Inflammatory Bowel Disease Questionnaire", 
                "measure": "IBDQ", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Intestinal mucosa of IL-6,IL-17,IL-23,etc", 
                "measure": "Inflammatory factors", 
                "safety_issue": "Yes", 
                "time_frame": "1 and a half years"
            }, 
            {
                "description": "5-HT,DA,etc", 
                "measure": "Neurotransmitter", 
                "safety_issue": "Yes", 
                "time_frame": "1 and a half years"
            }
        ], 
        "source": "Shanghai Institute of Acupuncture, Moxibustion and Meridian", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Institute of Acupuncture, Moxibustion and Meridian", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}